Search for Clinical Trial Results

Sponsored By

Gas Gangrene - 7 Studies Found

Status Study
Recruiting Study Name: Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
Condition:
  • Ischemic Stroke
  • Malignant Edema

Date: 2013-02-14
Interventions: Drug: RP-1127 (Glyburide for Injection) Glyburide (5-chloro-N-(4-[N-(cyclohexylcarbamoyl) sulfamoyl]phen
Recruiting Study Name: Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study
Condition:
  • Necrotizing Soft Tissue Infection
  • Necrotizing Fascitis
  • Date: 2017-04-26
    Interventions: Device: Hyperbaric oxygen therapy Hyperbaric oxygen therapy with 100 % oxygen at 1.8 ATA for 2 hours.
Recruiting Study Name: Modulation of Biomarkers in Patients With Flesh-eating Bacterial Infections After With Hyperbaric Oxygen Treatment
Condition:
  • Necrotizing Soft Tissue Infection
  • Necrotizing Fasciitis
  • Date: 2015-07-03
Completed Study Name: Biomarkers in Patients With Flesh-eating Bacterial Infections
Condition:
  • Necrotizing Soft Tissue Infection
  • Necrotizing Fasciitis
  • Date: 2014-06-29
Completed Study Name: Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
Condition:
  • Necrotizing Soft Tissue Infection
  • Necrotizing Fasciitis
  • Date: 2014-04-03
    Interventions:
    • Drug: IVIG (Privigen) Three do
Completed Study Name: Glyburide Advantage in Malignant Edema and Stroke Pilot
Condition: Ischemic Stroke
Date: 2010-12-29
Interventions: Drug: RP-1127 (Glyburide for injection) Bolus plus 72 hour IV infusion
Enrolling by invitation Study Name: Hyperbaric Oxygen Therapy Registry
Condition:
  • Air or Gas Embolism
  • Carbon Monoxide Poisoning
  • Date: 2015-05-28